Risk-based control for precise dosage in intravenous administration of anti-tumor drug phase 0 clinical trials
WANG Ze-juan
LIU Xiao-na
LIU Chen
CHEN Gang
WANG Jin
LIU Ying
LEI Chun-pu
FENG Li
JIN Hui
QI Lu
WANG Yu
WANG Xing-he
Machine-generated Keywords：
Publication Date：2018-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：5( 2286-2290 )